Save the date! On April 25th, don’t miss NIA’s webinar on Alzheimer’s disease risk across diverse populations. Explore how to use the Health & Aging Brain Study – Health Disparities infrastructure in your dementia research. Click here to see the presenters and to register!
For Dementia Researchers: Join NIA’s Webinar on April 25 Read More »
Alzheimers.gov Highlights Aging in a more disadvantaged neighborhood may worsen a person’s performance on cognitive tests, particularly if that individual is Mexican American, according to a recent NIA-funded study. A team of scientists analyzed data from 1,614 older adult participants in the Health and Aging Brain Study — Health Disparities. More than half of study
Studies have found that hearing loss is associated with dementia in older adults. While research suggests that using hearing aids to treat hearing loss may slow the development of cognitive decline in people with an increased risk, this had not been tested in a large, randomized study. To close this gap, NIH-funded researchers conducted a clinical
Research Highlight: Hearing Aids Slow Cognitive Decline in People at High Risk Read More »
Here’s a recap of NIA’s most popular Alzheimers.gov topics in 2023: Visit the Alzheimers.gov website to find the full range of Alzheimer’s and related dementias articles and resources as well as clinical trials in your area.
The Top Five Alzheimers.gov Articles of 2023 Read More »
Check out the latest in aging advances, research, and events from NIA: Read more of the latest NIA research news from the NIA newsroom.
Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a recently characterized type of dementia. Similar to other forms of brain disorders, such as Alzheimer’s disease, LATE causes problems with memory and thinking but has different underlying causes. Researchers identified LATE based on results of autopsy studies that revealed abnormal clusters of a protein called TDP-43. TDP-43 is
Interested in volunteering for research on Alzheimer’s disease, related dementias, and cognitive health? Learn about new and featured studies below or search for clinical trials and studies near you with the Alzheimers.gov Clinical Trials Finder. New and featured studies Click on the trial name for details and contact information. Caregiving Cognitive Training Daily Functioning Exercise and Supplements
Volunteers Needed for Studies to Advance Dementia Research Read More »
NIA-funded research suggests that existing treatments for vision problems — including eye exams, glasses prescriptions, and cataract surgery — could have potentially prevented about 100,000 cases of dementia in the United States. The study investigators used data from the University of Michigan Health and Retirement Study (HRS), a longitudinal study tracking changes in health and
Vision Impairment is Associated With as Many as 100,000 U.S. Dementia Cases Read More »
Biomarkers are measurable indicators of what’s happening in your body. They can be found in blood, other body fluids, organs, and tissues, and can be used to track healthy processes, disease progression, or even responses to medication. When combined with other tests, biomarkers can also help doctors determine whether a person might have or be
New Video: How Biomarkers Help Diagnose Dementia Read More »
Biomarkers are measurable indicators of what’s happening in your body. They can be found in blood, other body fluids, organs, and tissues, and can be used to track healthy processes, disease progression, or even responses to medication. When combined with other tests, biomarkers can also help doctors determine whether a person might have or be
New Video: How Biomarkers Help Diagnose Dementia Read More »
